NASDAQ · Medical - Instruments & Supplies

AtriCure, Inc. (ATRC) Stock

$55.81 +5.62% NASDAQ: ATRC Healthcare

Valuation

MetricValue
Price$55.81
Market Cap$2.84B
P/E Ratio265.65
P/B Ratio5.29
P/S Ratio5.03
EPS (TTM)$0.40
52-Week High$61.70
52-Week Low$25.36
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE2.14%
ROA1.56%
ROCE2.34%
Gross Margin75.47%
Operating Margin-0.36%
Net Margin1.85%
Debt/Equity0.14
Current Ratio3.94

Annual Financials (USD)

Metric20212022202320242025
Revenue$274.0M$330.0M$399.0M$465.0M$535.0M
Operating Profit$55.0M$-43.0M$-27.0M$-40.0M$-3.0M
Net Profit$50.0M$-46.0M$-30.0M$-45.0M$-11.0M
EPS$1.09$-1.02$-0.66$-0.95$-0.24
Op Margin20.1%-12.9%-6.7%-8.6%-0.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$615.0M$585.0M$614.0M$609.0M$654.0M
Total Liabilities$132.0M$129.0M$148.0M$148.0M$162.0M
Cash$44.0M$58.0M$84.0M$123.0M$167.0M
Borrowings$76.0M$75.0M$74.0M$77.0M$88.0M

Latest News

AtriCure to Announce Second Quarter 2026 Financial Results Business Wire · Jul 2, 2026 Edwards wins FDA clearance for LAA clip, setting up competition with AtriCure and Medtronic MedTech Dive · Jun 29, 2026 AtriCure (ATRC) Soars 6.2%: Is Further Upside Left in the Stock? Zacks · Jun 19, 2026 Do Options Traders Know Something About AtriCure Stock We Don't? Zacks · Jun 11, 2026 A Look At AtriCure (ATRC) Valuation As BoxX NoAF Trial Acceleration Draws Investor Attention Simply Wall St. · Jun 7, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-14.0M$-22.0M$4.0M$12.0M$57.0M
Investing Cash Flow$14.0M$27.0M$-20.0M$7.0M$-24.0M
Financing Cash Flow$-7.0M$-6.0M$1.0M$-2.0M$-11.0M
Net Cash Flow$2.0M$14.0M$26.0M$38.0M$45.0M
Free Cash Flow$-24.0M$-39.0M$-38.0M$-11.0M$48.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.22
EV / EBITDA102.04
FCF Yield2.03%
Quick Ratio3.19
Interest Coverage1.97
Return 1Y8.08%
Return 3Y-37.55%
Return 5Y-58.45%

Ownership

Insiders Held3.86%
Institutions Held102.21%
Institutions Float Held106.31%
Institutional HolderSharesReport Date
Blackrock Inc.4,042,6812026-03-31
Wellington Management Group, LLP3,382,5552026-03-31
Alliancebernstein L.P.3,258,8722026-03-31
Hood River Capital Management LLC3,117,5452026-03-31
Vanguard Portfolio Management LLC2,702,6322026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About AtriCure, Inc.

AtriCure, Inc. is led by CEO Michael H. Carrel, employs 1,300 people, headquartered in US, publicly traded since 2005.

AtriCure, Inc. (ATRC) stock trades at $55.81 with a market capitalization of $2.84B. The stock is valued at a price-to-earnings (P/E) ratio of 265.65, price-to-book of 5.29, price-to-sales of 5.03. Over the past 52 weeks the stock has ranged between $25.36 and $61.70, and currently trades 9.5% below its 52-week high.

On profitability, AtriCure, Inc. generates a return on equity (ROE) of 2.14%, return on capital employed of 2.34%, an operating margin of -0.36%, a net profit margin of 1.85%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides